Literature DB >> 2569522

3-Amino-1-hydroxypropylidene-1,1-diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats.

E J van Hoogdalem1, A T Wackwitz, A G de Boer, D D Breimer.   

Abstract

The promoting action of the calcium chelating compound EDTA on intestinal drug absorption is supposed to be based on Ca2+ depletion, inducing widening of tight junctions. The aim of the present study was to evaluate the effects of the calcium-binding agent 3-amino-1-hydroxypropylidene-1,1-diphosphonate disodium salt (APD) on rectal cefoxitin absorption in rats. The extent of rectal cefoxitin absorption was enhanced by 0.5 to 6% w/v of APD, on rectal infusion as well as on bolus delivery, the latter regimen tending to result in lower bioavailabilities. A maximal cefoxitin bioavailability of 85 +/- 10% was achieved by infusion with 4% w/v of APD, compared with 14 +/- 12% without APD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569522     DOI: 10.1111/j.2042-7158.1989.tb06468.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.

Authors:  H Cohen; I S Alferiev; J Mönkkönen; M J Seibel; T Pinto; A Ezra; V Solomon; D Stepensky; H Sagi; A Ornoy; N Patlas; G Hägele; A Hoffman; E Breuer; G Golomb
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Enhanced bioavailability of cefoxitin using palmitoyl L-carnitine. I. Enhancer activity in different intestinal regions.

Authors:  S C Sutton; E L LeCluyse; L Cammack; J A Fix
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.